A5081113806- Lymphoma Diagnosis and Treatment
- CAR-T cell therapy research
- Multiple and Secondary Primary Cancers
- CNS Lymphoma Diagnosis and Treatment
- Blood groups and transfusion
- Lung Cancer Treatments and Mutations
- Chronic Lymphocytic Leukemia Research
- Cutaneous lymphoproliferative disorders research
- Chronic Myeloid Leukemia Treatments
- Erythrocyte Function and Pathophysiology
- Frailty in Older Adults
- Plant and Fungal Interactions Research
- Acute Lymphoblastic Leukemia research
- Systemic Lupus Erythematosus Research
- Health Systems, Economic Evaluations, Quality of Life
- Platelet Disorders and Treatments
The University of Texas Health Science Center at San Antonio
2022-2024
The University of Texas Health Science Center at Houston
2024
South Texas Veterans Health Care System
2024
The University of Texas at San Antonio
2023
We performed a retrospective chart review of 6266 randomly selected DLBCL patients treated in the VHA nationwide between 1/1/2011 and 12/31/2021. The 3178 who met inclusion criteria were predominantly male (97%) white (75%). Median age diagnosis for Black was 63 years vs 69 entire cohort (
Abstract Background:Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare and distinct subtype of Lymphoma.(PMID 26149294) 80% manifest at early stages, with male black race predilection.(PMID 26149195) Previous analysis have shown similar survival Hispanics (HI) compared to Non-Hispanics (NH).(J Clin Oncol 10.1200/JCO.2023.41.16_suppl.e19512) This National Cancer Database (NCDB) aims clarify how sociodemographic factors affect presentation in HI vs NH patients NLPHL....
Abstract Background: Mantle cell lymphoma (MCL), represents 3% of new cases non-Hodgkin’s lymphomas.(PMID 29348844) MCL affects mainly males; factors like ethnicity, age at presentation can have prognostic implications. Currently, it isn’t clear if Hispanics (HI) a survival difference compared to Non-Hispanics (NH).(PMID 31029647, PMID 25315847). This National Cancer Database (NCDB) analysis aims clarify how sociodemographic affect and in HI vs NH patients with MCL. Methods: Data were...
Abstract Background: Diffuse Large B-Cell Lymphoma (DLBCL) is the most common Non-Hodgkin lymphoma in United States (US) but there limited evidence showing ethnic disparities affecting overall survival (OS) (Blood10.1182/blood-2022-159201, Blood10.1182/blood-2021-151816). This largest nationwide cancer registry analysis evaluating differences for HI vs Non-Hispanics (NH) with DLBCL US. Methods: Data were analyzed using National Cancer Database from 2004-2019. Sociodemographic characteristics...
e19514 Background: Classical Hodgkin Lymphoma (cHL) and it’s 4 subtypes, account for 95% of cases in Western countries (J Natl Compr Canc Netw PMID 35390768). Race is a known survival predictor this disease studies have shown that outcomes vary between Non-Hispanic (NH) Hispanic (HI) patients (Adv Hematol 21197477 Ann Oncol 22241896). This analysis attempts to clarify how sociodemographic characteristics influence HI diagnosed with cHL the United States (US). Methods: Retrospective data on...
Abstract Background: Primary Mediastinal B-cell Lymphoma (PMBL) is a rare, aggressive Non-Hodgkin (NHL) accounting for approximately 2-5% of all NHL (PMID: 34330673). Due to its rarity, there scarce literature on the demographic features PMBL. Moreover, little no research outcomes ethnic minority groups, particularly in Hispanics (HI) 27399089.) Thus, need further investigation disease characteristics advance treatment options future. This national scale population-based analysis examining...
e19505 Background: In essence, chronic lymphocytic leukemia (CLL) and small lymphoma (SLL) are the same , CLL being most common in Western countries. (Blood PMID 29540348, CA Cancer J Clin 35020204) Survival outcomes CLL/SLL among Hispanics (HI) Non-Hispanics (NH) have been controversial. (Cancer Causes Control 34677741, Cold Spring Harb Mol Case Stud 33593728) This analysis attempts to clarify if sociodemographic characteristics influence survival of HI diagnosed with United States (US)....
e18773 Background: Peripheral T cell lymphoma – not otherwise specified (PTCL-NOS), angioimmunoblastic T-cell (AITL) and anaplastic large (ALCL) are unusual non-Hodgkin lymphomas with miscellaneous clinical characteristics which share the same treatment regimen (Blood PMID28115372 Cancer Treat ResPMID30596215 Blood PMID28115369). Gene expression profiling has facilitated their diagnosis; but much remains to be learned about risk factors, biological implications (Oncologist PMID16880242)....
Introduction: Immune thrombocytopenia is a frequent hematologic manifestation in systemic lupus erythematosus (SLE). Corticosteroids are the first line of treatment for moderate to severe this disease, conjunction with antimalarials or other immunosuppressants. In particular cases where response initial interventions not achieved, second-line therapies different mechanisms action re available. Objective: This narrative review will focus on two thrombopoietin receptor agonist drugs (TPO-RA):...